Price To Earnings Ratio 20.52 | Sector PE 64.22 |
PB Ratio 2.99 | Sector PB 8.24 |
EPS 18.75 | Dividend Yield 0.00 |
Today's Volume 207.752 K | 5 Day Avg. Volume 170.122 K |
PEG Ratio 0.34 | Market Cap. ₹ 6,740.00 Cr. |
FDC Limited is an Indian company whose core business is the pharmaceutical industry. The company manufactures and distributes generic drugs, dosage forms and active ingredients in its own manufacturing facilities. It also manufactures oral rehydration salts (ORS) and specialty formulations. There is a selection of functional food and drinks. Its active pharmaceutical ingredients (API) include albuterol sulfate, bromhexine hydrochloride, cinnarizine, flunarizine dihydrochloride, flurbiprofen, flurbiprofen sodium, miconazole nitrate, and timolol maleate. It is found in various therapeutic segments such as anti-infective, gastrointestinal, ophthalmic, vitamins/minerals/dietary supplements, cardiac, diabetes, respiratory, gynecology, dermatology, analgesics and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.